Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (NaV) are transmembrane proteins that enable the rapid influx of sodium ions during the action potential in excitable cells such as neurons and cardiac myocytes. Local anesthetics bind primarily to the intracellular portion of these channels, preferentially interacting with the open or inactivated state of the channel, stabilizing its inactive conformation. This prevents the initiation and propagation of action potentials, resulting in temporary loss of sensation or pain in the area supplied by the blocked nerve[1][2][3][4][6][9]. Local anesthetics are structurally characterized by a lipophilic aromatic ring and a hydrophilic amine, linked by either an ester or amide group. The molecules must enter the nerve cell in their unionized form to access the binding site, which is more accessible when the sodium channel is open, explaining the use- or frequency-dependence of the block[1][2][9].
Blockade of voltage-gated sodium channels in their open or inactivated state, inhibiting action potential propagation and nerve signal transmission[1][2][3][4][6][7][9][10].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (alpha subunit) (NaV (Nav)).